BCIIX
Price
$18.20
Change
-$0.22 (-1.19%)
Updated
Jul 11 closing price
Net Assets
80.1M
RERHX
Price
$60.02
Change
-$0.46 (-0.76%)
Updated
Jul 11 closing price
Net Assets
134.71B
Interact to see
Advertisement

BCIIX vs RERHX

Header iconBCIIX vs RERHX Comparison
Open Charts BCIIX vs RERHXBanner chart's image
Brown Capital Mgmt Intl All Com I
Price$18.20
Change-$0.22 (-1.19%)
VolumeN/A
Net Assets80.1M
American Funds EUPAC R5E
Price$60.02
Change-$0.46 (-0.76%)
VolumeN/A
Net Assets134.71B
BCIIX vs RERHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BCIIX vs. RERHX commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCIIX is a Hold and RERHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERHX has more cash in the bank: 135B vs. BCIIX (80.1M). RERHX pays higher dividends than BCIIX: RERHX (0.85) vs BCIIX (0.00). BCIIX was incepted earlier than RERHX: BCIIX (26 years) vs RERHX (10 years). BCIIX (1.88) is less costly to investors than RERHX (0.62). BCIIX is a more actively managed with annual turnover of: 56.00 vs. RERHX (35.00). RERHX has a lower initial minimum investment than BCIIX: RERHX (250) vs BCIIX (5000). BCIIX annual gain was more profitable for investors over the last year : 4.66 vs. RERHX (3.08). BCIIX (14.80) and RERHX (14.21) have equivalent 5 years return.
BCIIXRERHXBCIIX / RERHX
Total Expense Ratio1.250.62202%
Annual Report Gross Expense Ratio1.880.62303%
Fund Existence26 years10 years-
Gain YTD9.30912.71473%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets80.1M135B0%
Annual Yield % from dividends0.000.85-
Returns for 1 year4.663.08151%
Returns for 3 years39.8932.27124%
Returns for 5 years14.8014.21104%
Returns for 10 years48.22N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XBIO3.980.15
+3.87%
Xenetic Biosciences
HBNC15.71-0.26
-1.63%
Horizon Bancorp
CRL159.40-4.26
-2.60%
Charles River Laboratories International
ODD71.17-2.02
-2.76%
ODDITY Tech Ltd
COYA6.13-0.19
-3.08%
Coya Therapeutics